|
Whether you want more information on alpha1-antitrypsin (AAT) deficiency, or tools to help you manage AAT deficiency, you'll find the resources you need in this section.
Insurance Support
Find out how to get answers to your insurance questions and help paying for your medication.
AlphaKit Test Kit
Learn how to test your AAT levels simply and conveniently.
Downloadable Tools
Information and tools to help you manage AAT deficiency.
News and Events
Recent news and events from Talecris Biotherapeutics.
Online Resources
A list of organizations for more information on AAT deficiency.
Register With Prolastin®
Sign up to receive updates about Prolastin® and our newsletter just for people with AAT deficiency.
Important Safety Information
Prolastin®, Alpha1-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha1-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.
You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please click here for Prolastin® full Prescribing Information.
Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.
|